Literature DB >> 15640505

Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.

Toshiyuki Suzuki1, Sotaro Sadahiro, Maki Fukasawa, Kenji Ishikawa, Akemi Kamijo, Seiei Yasuda, Hiroyasu Makuuchi, Yukio Ohizumi, Chieko Murayama.   

Abstract

OBJECTIVE: In order to determine the reliable predictors of response to radiotherapy for rectal cancer, we assessed apoptosis, p53 and p21 in biopsy specimens collected before treatment, and investigated the relationships to the histological effect of irradiation and the degree of tumor shrinkage.
METHODS: Ninety-three patients with advanced rectal adenocarcinoma were treated with preoperative irradiation of 20 Gy in 10 fractions in combination with intraoperative electron beam irradiation of 15 Gy. We evaluated tumor grade, pathological tumor regression, biological markers associated with apoptosis and proliferation [apoptotic index (AI), p53, p21 and Ki67], and the degree of tumor shrinkage.
RESULTS: Considering positivity of p21 and of apoptosis and negativity of p53 as favorable factors in tumor shrinkage, we compared the degree of shrinkage among the patients using the number of favorable factors as the score. The degree of shrinkage was 41.5 +/- 8.5% in patients with three favorable factors, 31.4 +/- 9.7% in patients with two favorable factors and 26.5 +/- 11.2% in patients with one favorable factor. However, there was no significant difference in the proportion of marked regression according to the number of favorable factors.
CONCLUSIONS: Histological examination of apoptosis, p21 and p53 in biopsy specimens and scoring were considered to be useful predictive methods for assessing the efficacy of radiotherapy for rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15640505     DOI: 10.1093/jjco/hyh140

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  10 in total

1.  Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy.

Authors:  Lukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Jacek Starzewski; Zbigniew Lorenc
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Akemi Kamijo; Takeshi Akiba; Shuichi Kawada
Journal:  Int J Clin Oncol       Date:  2015-04-02       Impact factor: 3.402

3.  Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response.

Authors:  Atsushi Ogura; Akiko Chino; Tsuyoshi Konishi; Takashi Akiyoshi; Teruhito Kishihara; Yoshiro Tamegai; Masashi Ueno; Masahiro Igarashi
Journal:  Int J Colorectal Dis       Date:  2015-01-09       Impact factor: 2.571

4.  Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.

Authors:  Inti Zlobec; Russell Steele; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Journal:  J Clin Pathol       Date:  2006-12-20       Impact factor: 3.411

5.  High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction.

Authors:  M Kikuchi; T Mikami; T Sato; W Tokuyama; K Araki; M Watanabe; K Saigenji; I Okayasu
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

6.  Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.

Authors:  Kazushige Kawai; Joji Kitayama; Nelson H Tsuno; Eiji Sunami; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

7.  Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets.

Authors:  Noriko Tada; Kazushige Kawai; Nelson H Tsuno; Soichiro Ishihara; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Koji Oba; Toshiaki Watanabe
Journal:  World J Surg Oncol       Date:  2015-02-07       Impact factor: 2.754

8.  Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Haruna Nishimaki; Shinobu Masuda
Journal:  Radiat Oncol       Date:  2017-01-13       Impact factor: 3.481

9.  Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.

Authors:  Sotaro Sadahiro; T Suzuki; A Tanaka; K Okada; G Saito; H Miyakita; T Ogimi; H Nagase
Journal:  Cancer Chemother Pharmacol       Date:  2017-04-17       Impact factor: 3.333

10.  P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.

Authors:  Min-Bin Chen; Xiao-Yang Wu; Rong Yu; Chen Li; Li-Qiang Wang; Wei Shen; Pei-Hua Lu
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.